313 related articles for article (PubMed ID: 24113587)
1. Role of hepatic progenitor cells in nonalcoholic fatty liver disease development: cellular cross-talks and molecular networks.
Carpino G; Renzi A; Onori P; Gaudio E
Int J Mol Sci; 2013 Oct; 14(10):20112-30. PubMed ID: 24113587
[TBL] [Abstract][Full Text] [Related]
2. Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease.
Nobili V; Carpino G; Alisi A; Franchitto A; Alpini G; De Vito R; Onori P; Alvaro D; Gaudio E
Hepatology; 2012 Dec; 56(6):2142-53. PubMed ID: 22467277
[TBL] [Abstract][Full Text] [Related]
3. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.
Richardson MM; Jonsson JR; Powell EE; Brunt EM; Neuschwander-Tetri BA; Bhathal PS; Dixon JB; Weltman MD; Tilg H; Moschen AR; Purdie DM; Demetris AJ; Clouston AD
Gastroenterology; 2007 Jul; 133(1):80-90. PubMed ID: 17631134
[TBL] [Abstract][Full Text] [Related]
4. Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease.
Jiao J; Sanchez JI; Saldarriaga OA; Solis LM; Tweardy DJ; Maru DM; Stevenson HL; Beretta L
JHEP Rep; 2023 Feb; 5(2):100628. PubMed ID: 36687470
[TBL] [Abstract][Full Text] [Related]
5. The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease.
Gadd VL; Skoien R; Powell EE; Fagan KJ; Winterford C; Horsfall L; Irvine K; Clouston AD
Hepatology; 2014 Apr; 59(4):1393-405. PubMed ID: 24254368
[TBL] [Abstract][Full Text] [Related]
6. Macrophage Activation in Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) Correlates with Hepatic Progenitor Cell Response via Wnt3a Pathway.
Carpino G; Nobili V; Renzi A; De Stefanis C; Stronati L; Franchitto A; Alisi A; Onori P; De Vito R; Alpini G; Gaudio E
PLoS One; 2016; 11(6):e0157246. PubMed ID: 27310371
[TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.
Kanda T; Goto T; Hirotsu Y; Masuzaki R; Moriyama M; Omata M
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102237
[TBL] [Abstract][Full Text] [Related]
8. Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells.
Kim M; Yang SG; Kim JM; Lee JW; Kim YS; Lee JI
Int J Mol Med; 2012 Sep; 30(3):473-9. PubMed ID: 22710359
[TBL] [Abstract][Full Text] [Related]
9. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.
Wei G; An P; Vaid KA; Nasser I; Huang P; Tan L; Zhao S; Schuppan D; Popov YV
Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G174-G188. PubMed ID: 31630534
[TBL] [Abstract][Full Text] [Related]
10. Iron overload in nonalcoholic steatohepatitis.
Fujita N; Takei Y
Adv Clin Chem; 2011; 55():105-32. PubMed ID: 22126026
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of disease progression in nonalcoholic fatty liver disease.
Jou J; Choi SS; Diehl AM
Semin Liver Dis; 2008 Nov; 28(4):370-9. PubMed ID: 18956293
[TBL] [Abstract][Full Text] [Related]
12. Markers in nonalcoholic steatohepatitis.
Armutcu F; Akyol S; Ucar F; Erdogan S; Akyol O
Adv Clin Chem; 2013; 61():67-125. PubMed ID: 24015600
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis and non-alcoholic fatty liver diseases.
Kanda T; Matsuoka S; Yamazaki M; Shibata T; Nirei K; Takahashi H; Kaneko T; Fujisawa M; Higuchi T; Nakamura H; Matsumoto N; Yamagami H; Ogawa M; Imazu H; Kuroda K; Moriyama M
World J Gastroenterol; 2018 Jul; 24(25):2661-2672. PubMed ID: 29991872
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
Manne V; Handa P; Kowdley KV
Clin Liver Dis; 2018 Feb; 22(1):23-37. PubMed ID: 29128059
[TBL] [Abstract][Full Text] [Related]
15. Ductular reaction in non-alcoholic fatty liver disease: When Macbeth is perverted.
He YH; Pan JX; Xu LM; Gu T; Chen YW
World J Hepatol; 2023 Jun; 15(6):725-740. PubMed ID: 37397935
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructure of liver progenitor/oval cells in children with nonalcoholic steatohepatitis.
Sobaniec-Łotowska ME; Lebensztejn DM; Lotowska JM; Kańczuga-Koda L; Sulkowski S
Adv Med Sci; 2011; 56(2):172-9. PubMed ID: 21940261
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.
Schuppan D; Schattenberg JM
J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():68-76. PubMed ID: 23855299
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease.
Charlton M; Viker K; Krishnan A; Sanderson S; Veldt B; Kaalsbeek AJ; Kendrick M; Thompson G; Que F; Swain J; Sarr M
Hepatology; 2009 Apr; 49(4):1375-84. PubMed ID: 19330863
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis.
Overi D; Carpino G; Franchitto A; Onori P; Gaudio E
Cells; 2020 Mar; 9(3):. PubMed ID: 32131439
[TBL] [Abstract][Full Text] [Related]
20. Hepatic Progenitor Cells in Action: Liver Regeneration or Fibrosis?
Kaur S; Siddiqui H; Bhat MH
Am J Pathol; 2015 Sep; 185(9):2342-50. PubMed ID: 26255773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
